Cell death in the peripheral nervous system: Potential rescue strategies

Neuroscientist

Volumn 8, Issue 1, 2002, Pages 62-72

  Windebank, Anthony J ^a   McDonald, Elizabeth ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell death; Neuropathy; Therapy; Treatment

Indexed keywords

ANTIOXIDANT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CASPASE; CERAMIDE; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN D1; CYTOCHROME C OXIDASE; DNA; GABAPENTIN; GRANZYME B; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PERFORIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BID; PROTEIN P75; RILUZOLE; SOMATOMEDIN C;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CALCIUM HOMEOSTASIS; CELL CYCLE; DNA DAMAGE; HUMAN; MEMBRANE DAMAGE; MITOCHONDRION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

EID: 0036157674     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385840200800111     Document Type: Review

References (71)

1. Human ICE/CED-3 protease nomenclature
2. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat
3. A controlled trial of riluzole in amyotrophic lateral sclerosis
4. Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons
5. Fas/Apo
6. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
7. Dexamethasone-induced thymocyte apoptosis: Apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases
8. Oxidative stress and motor neurone disease
9. Nerve conduction studies in patients treated with cis-diamminedichloroplatinum(II): A preliminary report
10. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
11. Analysis of the mechanism of loss of trophic factor dependence associated with neuronal maturation: A phenotype indistinguishable from Bax deletion
12. Insulin-like growth factors regulate neuronal differentiation and survival
13. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
14. The effects of FK506 on retinal ganglion cells after optic nerve crush
15. Neurotrophin signaling via Trks and p75
16. Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo
17. Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle
18. Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons
19. Ceramide initiates NF? B-mediated caspase activation in neuronal apoptosis
20. Mitochondria and apoptosis
21. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
22. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death
23. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familiar amyotrophic lateral sclerosis
24. Ceramide in apoptosis - Does it really matter?
25. Possible involvement of cytochrome c release and sequential activation of caspases in ceramide-induced apoptosis in SK-N-MC cells
26. Bax directly induces release of cytochrome c from isolated mitochondria
27. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function
28. Mechanisms mediating caspase activation in cell death
29. Functional role of caspase-1 and caspas-3 in an ALS transgenic mouse model
30. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
31. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy
32. The role of excitotoxicity in ALS - What is the evidence?
33. The neuroprotective agent riluzole inhibits release of L-glutamate and L-aspartate from slices of hippocampal area CA1
34. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
35. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis
36. Mechanisms of neurotoxic injury and cell death
37. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development
38. Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2
39. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy
40. Fas and Fas ligand: A death factor and its receptor
41. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria
42. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes
43. From bench to clinic with apoptosis-based therapeutic agents
44. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage
45. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis
46. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress
47. Putrescine-modified nerve growth factor: Bioactivity, plasma pharmacokinetics, blood-brain/nerve barrier permeability, and nervous system biodistribution
48. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor
49. NTR and Fas?
50. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease
51. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis
52. Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzole
53. Neurons undergo apoptosis in animal and cell culture models of diabetes
54. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal
55. Glutamate, excitotoxicity and amyotrophic lateral sclerosis
56. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization
57. How do cytotoxic lymphocytes kill their targets?
58. prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2
59. Immunophilins in the nervous system
60. Neural actions of immunophilin ligands
61. A summary of mechanistic hypotheses of gabapentin pharmacology
62. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis
63. Mass spectrometric identification of increased C16 ceramide levels during apoptosis
64. Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats
65. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen
66. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice
67. Diabetes and the nervous system
68. Bax involvement in p53-mediated neuronal cell death
69. Improvement of endoneurial lipid abnormalities in experimental diabetic neuropathy by oxygen modification
70. Y and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis
71. Bcl-2 interrupts the ceramide-mediated pathway of cell death